Literature DB >> 29094721

Colorectal cancer: miR-100 and miR-125b induce cetuximab resistance in CRC.

Hugh Thomas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29094721     DOI： 10.1038/nrgastro.2017.156

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling.

Authors:  Yuanyuan Lu; Xiaodi Zhao; Qi Liu; Cunxi Li; Ramona Graves-Deal; Zheng Cao; Bhuminder Singh; Jeffrey L Franklin; Jing Wang; Huaying Hu; Tianying Wei; Mingli Yang; Timothy J Yeatman; Ethan Lee; Kenyi Saito-Diaz; Scott Hinger; James G Patton; Christine H Chung; Stephan Emmrich; Jan-Henning Klusmann; Daiming Fan; Robert J Coffey
Journal:  Nat Med       Date:  2017-10-16       Impact factor: 53.440
  1 in total
  2 in total

1.  Interrogation of gender disparity uncovers androgen receptor as the transcriptional activator for oncogenic miR-125b in gastric cancer.

Authors:  Ben Liu; Meng Zhou; Xiangchun Li; Xining Zhang; Qinghua Wang; Luyang Liu; Meng Yang; Da Yang; Yan Guo; Qiang Zhang; Hong Zheng; Qiong Wang; Lian Li; Xinlei Chu; Wei Wang; Haixin Li; Fengju Song; Yuan Pan; Wei Zhang; Kexin Chen
Journal:  Cell Death Dis       Date:  2021-05-04       Impact factor: 8.469

Review 2.  The Relationship Between the Network of Non-coding RNAs-Molecular Targets and N6-Methyladenosine Modification in Colorectal Cancer.

Authors:  Senxu Lu; Xiangyu Ding; Yuanhe Wang; Xiaoyun Hu; Tong Sun; Minjie Wei; Xiaobin Wang; Huizhe Wu
Journal:  Front Cell Dev Biol       Date:  2021-12-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.